Truist cuts Ideaya Biosciences stock price target on revised estimates
Covered in this story
What has happened since
- Ideaya Biosciences Inc is up 3.3% since this was published.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Truist Securities’s $57 target on $IDYA is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
Truist Securities’s track record →Analyst targets on Ideaya Biosciences Inc
- Stifel: $34.3 → $48 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IDYA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ideaya Biosciences Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.